Schedule 13G ownership disclosure

ARROWHEAD PHARMACEUTICALS INC COM

COMMON STOCK · CUSIP: 04280A100

Event date: 2024-12-31

Filing-level shares
6,016,227.00
Percent of class
4.8%
  • STATE STREET CORPORATION

    Shares: 6,016,227.00 · Class: 4.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000093751-25-000046
Form type
SCHEDULE 13G
Filer
ARROWHEAD PHARMACEUTICALS, INC.
CIK
CIK 879407
Filed
Feb 05, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub